Trevi Therapeutics, Inc. (TRVI)
NASDAQ: TRVI · Real-Time Price · USD
17.26
+0.20 (1.17%)
Sep 4, 2026, 4:00 PM EDT - Market closed
Trevi Therapeutics Market Cap
Trevi Therapeutics has a market cap or net worth of $2.46 billion as of September 4, 2026. Its market cap has increased by 182.43% in one year.
Market Cap
2.46B
Enterprise Value
2.14B
1-Year Change
182.43%
Ranking
Category
Stock Price
$17.26
ChartMarket Cap Chart
Since May 7, 2019, Trevi Therapeutics's market cap has increased from $84.99M to $2.46B, an increase of 2,793.47%. That is a compound annual growth rate of 58.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 2.46B | 53.17% |
| Dec 31, 2025 | 1.61B | 336.04% |
| Dec 31, 2024 | 368.19M | 330.28% |
| Dec 29, 2023 | 85.57M | -26.01% |
| Dec 30, 2022 | 115.65M | 472.04% |
| Dec 31, 2021 | 20.22M | -54.55% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 7, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics | 2.60B |
| Vera Therapeutics | 2.59B |
| Precigen | 2.55B |
| Nektar Therapeutics | 2.53B |
| Mineralys Therapeutics | 2.49B |
| Pharvaris | 2.47B |
| Harmony Biosciences Holdings | 2.46B |
| Nuvation Bio | 2.39B |